Search Result "KB"
The Ubiquitin-Dependent Proteolytic System and other Potential Targets for the Modulation of Nuclear Factor-kB (NF-kB)
Journal: Current Drug Targets
Volume: 1 Issue: 4 Year: 2000 Page: 387-399
Author(s): M. Magnani, R. Crinelli, M. Bianchi, A. Antonelli
Role of the NF-kB Pathway in the Pathogenesis of Human Disease States
Journal: Current Molecular Medicine
Volume: 1 Issue: 3 Year: 2001 Page: 287-296
Author(s): Yumi Yamamoto, Richard B. Gaynor
Receptor for AGEs (RAGE) as Mediator of NF-kB Pathway Activation in Neuroinflammation and Oxidative Stress
Journal: CNS & Neurological Disorders - Drug Targets
Volume: 13 Issue: 9 Year: 2014 Page: 1615-1626
Author(s): Julio C. Tobon-Velasco,Elvis Cuevas,Mónica A. Torres-Ramos
Pyramidatine (Z88) Sensitizes Vincristine-Resistant Human Oral Cancer (KB/VCR) Cells to Chemotherapeutic Agents by Inhibition of P-glycoprotein
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 18 Issue: 2 Year: 2018 Page: 286-294
Author(s): Zulong Liu,Hengrui Zhu,Shijin Qu,Lisha Tang,Lihuan Cao,Wenbo Yu,Xianmei Yang,Songmin Jiang,Dayuan Zhu,Changheng Tan,Long Yu
Oleanolic Acid A-lactams Inhibit the Growth of HeLa, KB, MCF-7 and Hep-G2 Cancer Cell Lines at Micromolar Concentrations
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 16 Issue: 5 Year: 2016 Page: 579-592
Author(s): Barbara Bednarczyk-Cwynar,Piotr Ruszkowski,Teresa Bobkiewicz-Kozlowska,Lucjusz Zaprutko
Potent Anticancer Activities of Beauvericin Against KB Cells In Vitro by Inhibitingthe Expression of ACAT1 and Exploring Binding Affinity
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 22 Issue: 5 Year: 2022 Page: 897-904
Author(s): Haiming Zhou,Jing Zhang,Xiaoqing Chen,Shili Guo,Huimei Lin,Bo Ding,Hongbo Huang
Serum Sirtuin-1, HMGB1-TLR4, NF-KB and IL-6 Levels in Alzheimerâs:The Relation Between Neuroinflammatory Pathway and Severity ofDementia
Journal: Current Alzheimer Research
Volume: 19 Issue: 12 Year: 2022 Page: 841-848
Author(s):
Chemistry and Biology of Anti-Inflammatory Marine Natural Products:Molecules Interfering with Cyclooxygenase, NF-kB and Other Unidentified Targets
Journal: Current Medicinal Chemistry
Volume: 13 Issue: 1 Year: 2006 Page: 1947-1969
Author(s): Stefania Terracciano, Maurizio Aquino, Manuela Rodriquez, Maria Chiara Monti, Agostino Casapullo, Raffaele Riccio, Luigi Gomez-Paloma
The NF-kB Pathway as a Potential Target for Autoimmune Disease Therapy
Journal: Current Pharmaceutical Design
Volume: 10 Issue: 2 Year: 2004 Page: 2827-2837
Author(s): Susanne Bacher, M. Lienhard Schmitz
Extraction, Chemical Composition, Antioxidant Property, and In-vitro Anticancer Activity of Silymarin from Silybum marianum on Kb and A549 Cell Lines
Journal: Current Drug Discovery Technologies
Volume: 18 Issue: 4 Year: 2021 Page: 511-517
Author(s): Mojgan Azadpour,Mohammad Morad Farajollahi,Ali Mohammad Varzi,Pejman Hashemzadeh,Hossein Mahmoudvand,Mitra Barati